Democratic Rep. Jasmine Crockett of Texas is defending her remarks about her state's governor, Republican Greg Abbott. Crockett referred to Abbott, who is in a wheelchair, as "Governor Hot Wheels" ...
Nov 24 (Reuters) - Abbott Laboratories (ABT.N), opens new tab said on Monday it has begun a correction in the United States for certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus glucose monitoring ...
How do you stay tied to where you’re from, even when oceans away? Well, writing songs, for starters. Milwaukee native Kristin Edwards first became enamored with artistic and musical culture growing up ...
Abbott has issued a medical device correction for about 3 million Freestyle Libre 3 and 3 Plus sensors in the U.S. after determining that some sensors may provide incorrect low glucose readings, the ...
Medical malpractice: Suit alleges that medical providers failed to identify and report a visible pancreatic mass during initial CT scan, leading to delayed cancer diagnosis and treatment, resulting in ...
Two decisions by the Texas governor this week, including directing authorities to investigate an Islamic organization, come as the state sees an increase in anti-Muslim rhetoric. By Ruth Graham Ruth ...
Abbott announced on Thursday, Nov. 20 it plans to buy Exact Sciences, a Madison-based maker of cancer screening and diagnostic tests, in a deal valued at an estimated $23 billion, including debt. The ...
Exact Sciences Corporation stock surged after Abbott Laboratories announces a $21bn acquisition at $105 per share, driven by Exact's cancer diagnostics leadership. Exact Sciences boasts strong revenue ...
Abbott to buy Exact Sciences in $23 billion deal Exact's flagship colorectal cancer test to join Abbott's portfolio Abbott eyes international expansion for Exact's tests Aims for broad reimbursement ...
Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Abbott Laboratories $21 billion deal to acquire cancer test maker Exact ...
Abbott Laboratories ABT-1.10%decrease; red down pointing triangle agreed to acquire cancer diagnostics company Exact Sciences EXAS 0.04%increase; green up pointing triangle in a deal valued at about ...
In January, Exact Sciences CEO Kevin Conroy told us that 2025 was shaping up to be a transformative year for the diagnostics company. Three cancer test launches, multiple study readouts and one $23 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback